Therefore, the control of HT is extremely significant for the continued use of VEGFR-TKI and to achieve the optimal outcome in MKC treatment.
← all excerpts
Predictive factor and antihypertensive usage of tyrosine kinase inhibitor-induced hypertension in kidney cancer patients.
1
—
—